Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis
- 1 November 1999
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 117 (5), 1198-1204
- https://doi.org/10.1016/s0016-5085(99)70406-3
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyteJournal of Hepatology, 1995
- EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH MUSCLE CELL DNA SYNTHESIS INHIBITION OF BASIC FIBROBLAST GROWTH FACTOR AND PLATELET-DERIVED GROWTH FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506Transplantation, 1995
- Inhibition of Human B Lymphocyte Cell Cycle Progression and Differentiation by RapamycinCellular Immunology, 1994
- Effects of cyclosporine and rapamycin on immunoglobulin production by preactivated human B cellsClinical and Experimental Immunology, 1994
- Rapamycin Inhibits p34cdc2 Expression and Arrests T Lymphocyte Proliferation at the G1/S TransitionAnnals of the New York Academy of Sciences, 1993
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexesCell, 1991
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in murine schistosomiasisBiochemistry, 1987
- Fat-storing cells of the rat liver: Their isolation and purificationExperimental Cell Research, 1982